Cargando…
Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604708/ https://www.ncbi.nlm.nih.gov/pubmed/28955498 http://dx.doi.org/10.1136/rmdopen-2017-000492 |